Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...] …
Category: Providers
While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...] …
Sexually transmitted disease (STD) clinics in Tennessee may soon have to enter into contracts to receive 340B in-kind funding—and for-profit [...] …
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...] …
The dozens of health systems suing the federal government over the reversal of a pandemic-era 340B child site registration waiver [...] …
Drugmaker Genentech has formally issued contract pharmacy restrictions after it gave some 340B hospitals advance notice last month of its [...] …
Drug manufacturer AbbVie is adding a cancer treatment to the list of drug products that only will be available to [...] …
Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...] …
Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...] …
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...] …